Brian S. Lucas
13Patents
5h-index
84Co-inventors
65Inventor score
Filing activity: Feb 19, 2003 → Sep 13, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10100063B2 | Compounds that inhibit Mcl-1 protein | Chemistry; Metallurgy | 7 | Active |
| US9296736B2 | Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer | Chemistry; Metallurgy | 7 | Active |
| US6875866B2 | Process for synthesis of D1 receptor antagonists | Chemistry; Metallurgy | 6 | Expired |
| US9623018B2 | Processes of making and crystalline forms of a MDM2 inhibitor | Chemistry; Metallurgy | 5 | Active |
| US9593129B2 | Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer | Chemistry; Metallurgy | 5 | Active |
| US9801867B2 | Processes of making and crystalline forms of a MDM2 inhibitor | Chemistry; Metallurgy | 1 | Active |
| US11203601B2 | Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US9873701B2 | Heterocyclic compounds and their uses | Chemistry; Metallurgy | 0 | Active |
| US11001598B2 | Compounds that inhibit Mcl-1 protein | Chemistry; Metallurgy | 0 | Active |
| US11465963B2 | Tetrahydronaphthalene derivatives useful as Nrf2 activators | Chemistry; Metallurgy | 0 | Active |
| US10968181B2 | NRF2 activator | Emerging Cross-Sectional Technologies | 0 | Active |
| US10836779B2 | Compounds that inhibit MCL-1 protein | Chemistry; Metallurgy | 0 | Active |
| US9873704B2 | Heterocyclic compounds and their uses | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.